NASDAQ:TMDX | Free Cash Flow | TransMedics Group, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$24.53M$36.66M-$12.12M-165.74%
2025-12-31$34.51M$15.51M$19M18.03%
2025-03-31-$2.86M$27.04M-$29.89M-116.40%
2024-12-31$19.66M$13.61M$6.06M88.33%
2024-03-31-$3.44M$44.17M-$47.61M-390.32%
2023-12-31$8.3M$41.82M-$33.51M-831.41%
2023-03-31-$8.66M$927,000.00-$9.59M
2022-12-31-$4.04M$2.76M-$6.8M
2022-03-31-$18.41M$1.95M-$20.36M
2021-12-31-$6.65M$3.18M-$9.83M
2021-03-31-$7.33M$20,000.00-$7.35M
2020-12-31-$7.14M$2,000.00-$7.14M
2020-03-31-$8.18M$277,000.00-$8.45M
2019-12-28-$7.26M-$19,000.00-$7.28M
2019-03-30-$7.27M$3,000.00-$7.27M
2018-03-31-$6.33M$40,000.00-$6.37M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$192.84M$59.25M$133.59M70.20%
2024-12-31$48.8M$129.74M-$80.94M-228.23%
2023-12-31-$13.03M$151.85M-$164.88M
2022-12-31-$45.82M$11.91M-$57.72M
2021-12-31-$28.86M$3.52M-$32.38M
2020-12-31-$30.27M$455,000.00-$30.72M
2019-12-28-$32.29M$165,000.00-$32.45M
2018-12-29-$25.98M$418,000.00-$26.4M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.